Can a simple Finger-Stick replace lab tests for rare metabolic disease?
NCT ID NCT06843330
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether portable lactate monitors (like those used at home) give accurate results for people with glycogen storage disease type Ia. Ten participants will have their lactate and glucose levels measured by finger-stick and by standard lab tests. The goal is to see if home devices can reliably track the disease, potentially reducing the need for frequent hospital visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If accurate, home lactate meters could help patients and doctors monitor the disease more easily without frequent lab visits.
- What could go wrong
- This is a small observational study with only 10 participants, so results may not apply to everyone. The devices may not be as accurate as lab tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLYCOGEN STORAGE DISEASE TYPE IA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Connecticut Children's Medical Center
RECRUITINGHartford, Connecticut, 06107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can home tests replace lab draws for rare disease patients?
- Gene therapy for rare Sugar-Storage disease shows promise in Long-Term safety check
- Gene therapy breakthrough aims to control rare metabolic disease
- Gene therapy could free GSD ia patients from constant cornstarch
- GSDIa patients monitored for 10 years after gene therapy